Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mycosis Fungoides × Pharmacogenomic Testing × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Malignant Tumor of Ill-defined Site 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1

Interventions

fludarabine phosphate 16 Whole-Body Irradiation 13 Mycophenolic Acid 13 Peripheral Blood Stem Cell Transplantation 12 Cyclosporine 10 Cyclophosphamide 10 Tacrolimus 9 Antilymphocyte Serum 9 Busulfan 8 Methotrexate 7 Etoposide 6 Rituximab 5 Melphalan 5 Flow Cytometry 5 Lenalidomide 4 Filgrastim 4 Everolimus 4 Dexamethasone 4 Calcium Dobesilate 4 Bexarotene 4 thymoglobulin 3 romidepsin 3 pembrolizumab 3 hypericin 3 Therapeutics 3 Sirolimus 3 Radiotherapy 3 Panobinostat 3 In Situ Hybridization, Fluorescence 3 Immunohistochemistry 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡